For PP2A, Zhou P et al. demonstrated its participation in T-cell-mediated tumor immunity, as PP2R2D-silenced CD4+ and CD8+ T cells exhibit increased viability and increased production of interferon-γ (IFN-γ), IL-2 and GM-CSF 6. The gene discussed is PTPA; the disease is neoplasm.